These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 18211933

  • 1. Immunohistochemical localisation of intravitreally injected bevacizumab in the anterior chamber angle, iris and ciliary body of the primate eye.
    Peters S, Heiduschka P, Julien S, Bartz-Schmidt KU, Schraermeyer U.
    Br J Ophthalmol; 2008 Apr; 92(4):541-4. PubMed ID: 18211933
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical localisation of intravitreally injected bevacizumab at the posterior pole of the primate eye: implication for the treatment of retinal vein occlusion.
    Julien S, Heiduschka P, Hofmeister S, Schraermeyer U.
    Br J Ophthalmol; 2008 Oct; 92(10):1424-8. PubMed ID: 18815425
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.
    Nomoto H, Shiraga F, Kuno N, Kimura E, Fujii S, Shinomiya K, Nugent AK, Hirooka K, Baba T.
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4807-13. PubMed ID: 19324856
    [Abstract] [Full Text] [Related]

  • 4. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
    Ishibashi S, Tawara A, Sohma R, Kubota T, Toh N.
    Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
    [Abstract] [Full Text] [Related]

  • 5. Penetration of bevacizumab through the retina after intravitreal injection in the monkey.
    Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, Schraermeyer U, Tübingen Bevacizumab Study Group.
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2814-23. PubMed ID: 17525217
    [Abstract] [Full Text] [Related]

  • 6. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.
    Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU, Tübingen Bevacizumab Study Group, Schraermeyer U.
    Am J Ophthalmol; 2007 Jun; 143(6):995-1002. PubMed ID: 17449002
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes.
    Miyake T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ogasawara K, Ohji M.
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1606-8. PubMed ID: 19875666
    [Abstract] [Full Text] [Related]

  • 8. Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes.
    Matsuyama K, Ogata N, Matsuoka M, Wada M, Nishimura T, Takahashi K.
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):379-83. PubMed ID: 21810018
    [Abstract] [Full Text] [Related]

  • 9. Bevacizumab clearance through the iridocorneal angle following intravitreal injection in a rat model.
    Gal-Or O, Dotan A, Dachbash M, Tal K, Nisgav Y, Weinberger D, Ehrlich R, Livnat T.
    Exp Eye Res; 2016 Apr; 145():412-416. PubMed ID: 26923799
    [Abstract] [Full Text] [Related]

  • 10. Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes.
    Inan UU, Avci B, Kusbeci T, Kaderli B, Avci R, Temel SG.
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1773-81. PubMed ID: 17389511
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of intravitreal bevacizumab (Avastin).
    Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ.
    Ophthalmology; 2007 May; 114(5):855-9. PubMed ID: 17467524
    [Abstract] [Full Text] [Related]

  • 12. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
    Lassota N, Prause JU, Scherfig E, Kiilgaard JF, la Cour M.
    Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
    [Abstract] [Full Text] [Related]

  • 13. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes.
    Sakurai K, Akiyama H, Shimoda Y, Yoshida I, Kurabayashi M, Kishi S.
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4905-16. PubMed ID: 19407010
    [Abstract] [Full Text] [Related]

  • 14. Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans.
    Meyer CH, Krohne TU, Holz FG.
    Acta Ophthalmol; 2012 Feb; 90(1):68-70. PubMed ID: 20163369
    [Abstract] [Full Text] [Related]

  • 15. Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans.
    Krohne TU, Eter N, Holz FG, Meyer CH.
    Am J Ophthalmol; 2008 Oct; 146(4):508-12. PubMed ID: 18635152
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A.
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [Abstract] [Full Text] [Related]

  • 17. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y, Higashide T, Takeda H, Murotani E, Ohkubo S, Sugiyama K.
    Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
    [Abstract] [Full Text] [Related]

  • 18. Serum concentration of bevacizumab after intravitreal injection in experimental branch retinal vein occlusion.
    Chuang LH, Wu WC, Yeung L, Wang NK, Hwang YS, Chen KJ, Kuo JZ, Lai CC.
    Ophthalmic Res; 2011 Jun; 45(1):31-5. PubMed ID: 20714188
    [Abstract] [Full Text] [Related]

  • 19. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.
    Avisar I, Weinberger D, Kremer I.
    Curr Eye Res; 2010 Feb; 35(2):108-15. PubMed ID: 20136420
    [Abstract] [Full Text] [Related]

  • 20. Long-term tolerability and serum concentration of bevacizumab (avastin) when injected in newborn rabbit eyes.
    Wu WC, Lai CC, Chen KJ, Chen TL, Wang NK, Hwang YS, Yeung L, Li LM.
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3701-8. PubMed ID: 20181842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.